-transparent.png){kind=logo}
In a light-dark choice situation, the alpha-2 adrenoceptor antagonist idazoxan shows anxiogenic-like effects, which cannot be blocked by the alpha-2 adrenoceptor agonist clonidine, or by the benzodiazepine receptor antagonist Ro 15-1788. In a conditioned conflict situation, both idazoxan and the alpha-2-adrenoceptor yohimbine show anxiogenic-like effects; the effect of idazoxan could not be blocked by clonidine or Ro 15-1788. These data suggest that systems other than alpha-2 adrenoceptors or benzodiazepine receptors must be found to explain these anxiogenic-like properties.
Related Publications
P Venault, and
F Jacquot, and
E Save, and
S Sara, and
G Chapouthier
February 1999,
Brain research,
P Venault, and
F Jacquot, and
E Save, and
S Sara, and
G Chapouthier
July 1974,
Archives internationales de pharmacodynamie et de therapie,
P Venault, and
F Jacquot, and
E Save, and
S Sara, and
G Chapouthier
January 1992,
European archives of psychiatry and clinical neuroscience,
P Venault, and
F Jacquot, and
E Save, and
S Sara, and
G Chapouthier
June 2008,
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology,
P Venault, and
F Jacquot, and
E Save, and
S Sara, and
G Chapouthier
April 1992,
Pharmacology, biochemistry, and behavior,
P Venault, and
F Jacquot, and
E Save, and
S Sara, and
G Chapouthier
October 1986,
Life sciences,
P Venault, and
F Jacquot, and
E Save, and
S Sara, and
G Chapouthier
January 1996,
Proceedings of the Western Pharmacology Society,
P Venault, and
F Jacquot, and
E Save, and
S Sara, and
G Chapouthier
March 2001,
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology,
P Venault, and
F Jacquot, and
E Save, and
S Sara, and
G Chapouthier
October 2015,
Behavioural pharmacology,
P Venault, and
F Jacquot, and
E Save, and
S Sara, and
G Chapouthier
January 1988,
Psychopharmacology,
